Fields »
ABOUT
HELP
BLOG

646 GENES FOUND

Show / hide columns »

XML | RDF | TAB | « prev | Page of 13 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Cancer

 

 

 

 

 

 

Subcellular location

x

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
DDR2Discoidin domain receptor tyrosine kinase 2CD markers
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Actin filaments		Mixed
DHFRDihydrofolate reductaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
MitochondriaMixed
DHODHDihydroorotate dehydrogenase (quinone)Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Mitochondria		Mixed
DNMT1DNA (cytosine-5-)-methyltransferase 1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transcription factors
NucleoplasmExpressed in all
DPEP1Dipeptidase 1 (renal)Enzymes
FDA approved drug targets
Predicted secreted proteins
Nucleus
Cell Junctions		Tissue enhanced
DPP4Dipeptidyl-peptidase 4CD markers
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
DRD1Dopamine receptor D1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
DRD2Dopamine receptor D2FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enriched
DRD3Dopamine receptor D3Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enriched
DRD4Dopamine receptor D4FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Not detected
DRD5Dopamine receptor D5Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
EDNRAEndothelin receptor type ADisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
EDNRBEndothelin receptor type BDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cytosol		Tissue enhanced
EGFEpidermal growth factorCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Tissue enriched
EGFREpidermal growth factor receptorCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Plasma membraneTissue enhanced
ELANEElastase, neutrophil expressedCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
EPHA2EPH receptor A2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
RAS pathway related proteins
VesiclesTissue enhanced
EPORErythropoietin receptorCancer-related genes
Disease related genes
FDA approved drug targets
Predicted membrane proteins
VesiclesTissue enhanced
ERBB2Erb-b2 receptor tyrosine kinase 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Plasma membrane
Cytosol		Expressed in all
ERBB4Erb-b2 receptor tyrosine kinase 4Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
ESR1Estrogen receptor 1Cancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Nucleus
Vesicles		Group enriched
ESR2Estrogen receptor 2 (ER beta)Cancer-related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
NucleoplasmTissue enhanced
ESRRGEstrogen-related receptor gammaFDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
NucleusTissue enhanced
F10Coagulation factor XCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
F11Coagulation factor XICandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesTissue enhanced
F2Coagulation factor II (thrombin)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
F2RCoagulation factor II (thrombin) receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
F5Coagulation factor V (proaccelerin, labile factor)Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Golgi apparatusGroup enriched
F7Coagulation factor VII (serum prothrombin conversion accelerator)Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
F8Coagulation factor VIII, procoagulant componentCandidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
F9Coagulation factor IXCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
FADS1Fatty acid desaturase 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
FADS2Fatty acid desaturase 2Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
FASNFatty acid synthaseCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol		Expressed in all
FCER1AFc fragment of IgE, high affinity I, receptor for; alpha polypeptideFDA approved drug targets
Predicted membrane proteins
Mixed
FCER1GFc fragment of IgE, high affinity I, receptor for; gamma polypeptideFDA approved drug targets
Predicted membrane proteins
Expressed in all
FCGR1AFc fragment of IgG, high affinity Ia, receptor (CD64)CD markers
FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
FCGR1BFc fragment of IgG, high affinity Ib, receptor (CD64)FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
FCGR2AFc fragment of IgG, low affinity IIa, receptor (CD32)CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
FCGR2BFc fragment of IgG, low affinity IIb, receptor (CD32)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Tissue enriched
FCGR3AFc fragment of IgG, low affinity IIIa, receptor (CD16a)CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
FCGR3BFc fragment of IgG, low affinity IIIb, receptor (CD16b)CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
FDPSFarnesyl diphosphate synthaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Cytosol		Expressed in all
FFAR1Free fatty acid receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
FGAFibrinogen alpha chainCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
FGF1Fibroblast growth factor 1 (acidic)Cancer-related genes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
NucleoplasmTissue enhanced
FGF2Fibroblast growth factor 2 (basic)Cancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Nucleoplasm
Nuclear bodies		Mixed
FGFR1Fibroblast growth factor receptor 1Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
NucleoliExpressed in all
FGFR2Fibroblast growth factor receptor 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
VesiclesMixed
FGFR3Fibroblast growth factor receptor 3Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Endoplasmic reticulumTissue enriched

« prev | Page of 13 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.